Preview

Rheumatology Science and Practice

Advanced search

SIGNS OF ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND CORONARY HEART DISEASE

https://doi.org/10.14412/1995-4484-2017-382-387

Abstract

Increased arterial stiffness is one of the additional risk factors (RFs) for cardiovascular diseases along with traditional RFs, such as male gender, age, dyslipidemia, hypertension, and smoking. In rheumatoid arthritis (RA), the risk of cardiovascular events, including coronary heart disease (CHD), is significantly higher than that in the general population, which may be associated with the characteristics of the underlying disease or the prevalence of traditional RFs.

Subjects and methods. The results of investigating the arterial stiffness in 56 patients including 46 with RA and 10 with CHD without inflammatory joint disease (a control group) were analyzed. Arterial stiffness was assessed by carotidfemoral pulse wave velocity (cfPWV) in the area from the carotid artery to the femoral one, which was determined by applanation tonometry, as well as by CAVI that was calculated according to the data of volume sphygmography.

Results and discussion. According to the investigation encompassing exercise tests and coronary angiography, the group of patients with RA was divided into two subgroups, depending on the presence or absence of coronary artery disease caused by atherosclerosis. The patients' age was 38 to 77 years (mean age 60.3±7.2 years); the male proportion was 34.8%.

Conclusion. The presence of RA with and without CHD is associated with a significant rise in arterial stiffness compared to isolated CHD (cfPWV, 13.6 and 8.6 m/sec, respectively). The increase in cfPWV and CAVI compared with the age norm was revealed in the majority of RA patients both with and without CHD.

About the Authors

L. B. Kruglyi
A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Research and Production Complex, Ministry of Health of Russia
Russian Federation

15A, Third Cherepkovskaya St., Moscow 121552



A. R. Zairova
A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Research and Production Complex, Ministry of Health of Russia
Russian Federation
15A, Third Cherepkovskaya St., Moscow 121552


O. A. Fomicheva
A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Research and Production Complex, Ministry of Health of Russia
Russian Federation
15A, Third Cherepkovskaya St., Moscow 121552


Yu. A. Karpov
A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Research and Production Complex, Ministry of Health of Russia
Russian Federation
15A, Third Cherepkovskaya St., Moscow 121552


A. N. Rogoza
A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Research and Production Complex, Ministry of Health of Russia
Russian Federation
15A, Third Cherepkovskaya St., Moscow 121552


E. V. Gerasimova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


D. S. Novikova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


T. V. Popkova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522


E. L. Nasonov
V.A. Nasonova Research Institute of Rheumatology I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation

34A, Kashirskoe Shosse, Moscow 115522

Department of Rheumatology, Institute of Professional Education

8, Trubetskaya St., Build. 2, Moscow 119991



References

1. Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006 Oct;36(2):88-98. doi: 10.1016/j.semarthrit.2006.04.006

2. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population- based analysis of trends over 40 years. Arthritis Rheum. 2003 Jan;48(1):54-8. doi: 10.1002/art.10705

3. Solomon DH, Kremer J, Curtis JR, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010 Nov;69(11):1920-5. doi: 10.1136/ard.2009.122226

4. Watson DJ, Rhodes T, Guess HA. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol. 2003 Jun;30(6):1196-202.

5. Wang S, Yiu KH, Mok MY, et al. Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis. J Intern Med. 2009 Nov;266(5):445-52. doi: 10.1111/j.1365-2796.2009.02123.x

6. Catapano AL, Graham I, de Backer G, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016 Oct;253:281-344. doi: 10.1016/j.atherosclerosis.2016.08.018

7. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016 May.

8. Del Rincon I, O’Leary DH, Freeman GL, et al. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis. 2007 Dec;195(2):354-60. doi: 10.1016/j.atherosclerosis.2006.09.027

9. Poole CD, Conway P, Currie CJ. An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice. Rheumatology (Oxford). 2009 Jan;48(1):78-82. doi: 10.1093/rheumatology/ken415

10. Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a metaanalysis of observational studies. Ann Rheum Dis. 2012 Sep;71(9):1524-9. doi: 10.1136/annrheumdis-2011-200726

11. Lopez-Longo FJ, Oliver-Minarro D, de la Torre I, et al. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum. 2009 Apr 15;61(4):419-24. doi: 10.1002/art.24390

12. Choy E, Ganeshalingam K, Semb AG, et al. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford). 2014 Dec;53(12):2143-54. doi: 10.1093/rheumatology/keu224

13. Inoue N, Maeda R, Kawakami H, et al. Aortic pulse wave velocity predicts cardiovascular mortality in middle-aged and elderly Japanese men. Circ J. 2009 Mar;73(3):549-53. doi: 10.1253/circj.CJ-08-0492

14. Peters MJL, Symmons DPM, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2009.

15. Новикова ДС, Попкова ТВ, Мач ЭС, Насонов ЕЛ. Ригидность артерий – интегральный показатель сердечно- сосудистого риска у больных ревматоидным артритом. Научно- практическая ревматология. 2009;47(5):38-47 [Novikova DS, Popkova TV, Mach ES, Nasonov EL. Arteries rigidity – integral index of cardiovascular risk in patients with rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2009;47(5):38-47 (In Russ.)]. doi: 10.14412/1995-4484-2009-587

16. Agca R, Heslinga SC, Rollefstad S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2016 Sept.

17. Новикова ДС, Попкова ТВ, Герасимов АН и др. Взаимосвязь кардиоваскулярных факторов риска с ригидностью артериальной стенки у женщин с высокой активностью ревматоидного артрита. Рациональная фармакотерапия в кардиологии. 2012;8(6):756- 65 [Novikova DS, Popkova TV, Gerasimov AN, et al. Interrelation of cardiovascular risk factors with arterial wall rigidity in women with high activity of rheumatoid arthritis. Ratsional'naya Farmakoterapiya v Kardiologii. 2012;8(6):756-65 (In Russ.)].

18. Van Bortel LM, Laurent S, Boutouyrie P, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012 Mar;30(3):445-8. doi: 10.1097/HJH.0b013e32834fa8b0

19. Wong M, Toh L, Wilson A, et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum. 2003 Jan;48(1):81-9. doi: 10.1002/art.10748

20. Roman MJ, Devereux RB, Schwartz JE, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension. 2005 Jul;46(1):194-9. doi: 10.1161/01.HYP.0000168055.89955.db

21. Mä ki-Petä jä KM, Hall FC, Booth AD, et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation. 2006 Sep 12;114(11):1185-92. doi: 10.1161/CIRCULATIONAHA.105.601641

22. Kerekes G, Soltesz P, Nurmohamed MT, et al. Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol. 2012 Feb 21;8(4):224-34. doi: 10.1038/nrrheum.2012.16

23. Mattace-Raso F, Hofman A, Verwoert GC, et al. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: establishing normal and reference values. Eur Heart J. 2010 Oct;31(19):2338-50. doi: 10.1093/eurheartj/ehq165

24. Рогоза АН, Заирова АР, Жернакова ЮВ и др. Состояние сосудистой стенки в популяции взрослого населения на примере жителей Томска, по данным исследования ЭССЕ-РФ. Системные гипертензии. 2014;11(4):42-8 [Rogoza AN, Zairova AR, Zhernakova YuV, et al. The state of the vascular wall in the adult population by the example of Tomsk residents, according to the data of the ESSE-RF study. Sistemnye Gipertenzii. 2014;11(4):42-8 (In Russ.)].

25. Soltesz P, Der H, Kerekes G, et al. A comparative study of arterial stiffness, flow- mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima– media in patients with systemic autoimmune diseases. Clin Rheumatol. 2009 Jun;28(6):655- 62. doi: 10.1007/s10067-009-1118-y

26. Рогоза АН, Балахонова ТВ, Чихладзе НМ. Современные методы оценки состояния сосудов у больных артериальной гипертонией. Москва; 2008. 72 c. [Rogoza AN, Balakhonova TV, Chikhladze NM. Sovremennye metody otsenki sostoyaniya sosudov u bol'nykh arterial'noy gipertoniey [Modern methods of assessing the state of blood vessels in patients with arterial hypertension]. Mosow; 2008. 72 p.].

27. Милягин ВА, Милягина ИВ, Абраменкова НЮ и др. Неинвазивные методы исследования магистральных сосудов. Смоленск; 2008. 182 с. [Milyagin VA, Milyagina IV, Abramenkova NYu, et al. Neinvazivnye metody issledovaniya magistral'nykh sosudov [Non- invasive methods for the study of major vessels]. Smolensk; 2008. 182 p.].


Review

For citations:


Kruglyi L.B., Zairova A.R., Fomicheva O.A., Karpov Yu.A., Rogoza A.N., Gerasimova E.V., Novikova D.S., Popkova T.V., Nasonov E.L. SIGNS OF ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND CORONARY HEART DISEASE. Rheumatology Science and Practice. 2017;55(4):382-387. (In Russ.) https://doi.org/10.14412/1995-4484-2017-382-387

Views: 1337


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)